Annual report pursuant to Section 13 and 15(d)

Accrued Expenses (Tables)

v3.24.1
Accrued Expenses (Tables)
12 Months Ended
Dec. 31, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consist of the following as of December 31, 2023 and 2022 (in thousands):

 

 

 

 

December 31, 2023

 

 

December 31, 2022

 

External research and preclinical development

 

 

$

8,001

 

 

$

8,219

 

Employee compensation and benefits

 

 

 

6,993

 

 

 

8,529

 

Professional fees

 

 

 

1,015

 

 

 

1,164

 

Facilities and other

 

 

 

137

 

 

 

54

 

Accrued expenses

 

 

$

16,146

 

 

$

17,966